{
    "data": [
        {
            "id": "tag:reuters.com,2026-02-26:newsml_RSZ5996Ua:0",
            "title": "REG - JPMorgan Japanese IT - Transaction in Own Shares",
            "description": "<div class=\"body-KX2tCBZq body-nzzZVyQ3 content-nzzZVyQ3\"><div class=\"symbolsContainer-uFduEtAF logosContainer-diQOvrPB\" data-no-swipe=\"true\"></div><div><span><span>RNS Number : 5996U  JPMorgan Japanese Inv. Trust PLC  26 February 2026   </span><p class=\"\"><span>LONDON STOCK EXCHANGE ANNOUNCEMENT</span></p><p class=\"\"><span>JPMORGAN JAPANESE INVESTMENT TRUST PLC</span></p><p class=\"\"><span>(the 'Company')</span></p><p class=\"\"><span>REPURCHASE OF ORDINARY SHARES INTO TREASURY</span></p><p class=\"\"><span>Legal Entity Identifier: 549300JZW3TSSO464R15</span></p><p class=\"\"><span>The Company announces that it has today repurchased 25,000 Ordinary Shares into Treasury at 827.00 pence per share.</span></p><p class=\"\"><span>Following the transaction, the Company holds 26,276,985 shares in Treasury. The shares in issue less the total number of Treasury shares is 158,336,203. The Company will only re-issue shares held in Treasury at a premium to net asset value.</span></p><p class=\"\"><span>26th February 2026</span></p><p class=\"\"><span>For further information, please contact:</span></p><p class=\"\"><span>Priyanka Vijay Anand</span></p><p class=\"\"><span>JPMorgan Funds Limited - Company Secretary</span></p><p class=\"\"><span>Telephone 0800 20 40 20 (or +44 1268 44 44 70 )</span></p><span>This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.</span><p class=\"\"><span>RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.   END  POSDQLFLQLLBBBD</span></p></span></div></div>",
            "link": "https://www.tradingview.com/news/reuters.com,2026-02-26:newsml_RSZ5996Ua:0-reg-jpmorgan-japanese-it-transaction-in-own-shares/",
            "pub_date": "2026-02-27 01:08:43",
            "source": "London Stock Exchange",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "urn:summary_document_transcript:quartr.com:2938324:0",
            "title": "IBAT: Net income turned positive on non-cash gains as focus shifts to commercial execution and contracts",
            "description": "<div class=\"body-KX2tCBZq body-nzzZVyQ3 content-nzzZVyQ3\"><div class=\"symbolsContainer-uFduEtAF logosContainer-diQOvrPB\" data-no-swipe=\"true\"></div><div><span><p class=\"\"><span>Q3 2026 saw modest service revenue and a net income turnaround due to non-cash warrant gains, while the company remains pre-commercial and focused on securing commercial contracts. Strategic priorities include full flow sheet solutions, technology upgrades, and maintaining strong liquidity.</span></p><p class=\"\"><span>Based on </span></p><section class=\"variant-secondary-aHOVUrmQ disclaimer-fdvjGD1u\"><b class=\"heading-wrapper-aHOVUrmQ\"><span class=\"heading-aHOVUrmQ\">Disclaimer</span></b><div class=\"content-aHOVUrmQ link-with-underline-aHOVUrmQ\"><span>This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.</span></div></section></span></div></div>",
            "link": "https://www.tradingview.com/news/urn:summary_document_transcript:quartr.com:2938324:0-ibat-net-income-turned-positive-on-non-cash-gains-as-focus-shifts-to-commercial-execution-and-contracts/",
            "pub_date": "2026-02-27 01:08:44",
            "source": "Quartr",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "urn:summary_document_transcript:quartr.com:2938325:0",
            "title": "KRP: Q4 2025 saw record production, higher distributions, and a robust outlook for 2026",
            "description": "<div class=\"body-KX2tCBZq body-nzzZVyQ3 content-nzzZVyQ3\"><div class=\"symbolsContainer-uFduEtAF logosContainer-diQOvrPB\" data-no-swipe=\"true\"></div><div><span><p class=\"\"><span>Strong Q4 and full-year 2025 results featured organic production growth, a major Permian acquisition, and increased distributions. Financial discipline reduced debt, while 2026 guidance signals stable production and continued M&amp;A opportunities.</span></p><p class=\"\"><span>Based on </span></p><section class=\"variant-secondary-aHOVUrmQ disclaimer-fdvjGD1u\"><b class=\"heading-wrapper-aHOVUrmQ\"><span class=\"heading-aHOVUrmQ\">Disclaimer</span></b><div class=\"content-aHOVUrmQ link-with-underline-aHOVUrmQ\"><span>This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.</span></div></section></span></div></div>",
            "link": "https://www.tradingview.com/news/urn:summary_document_transcript:quartr.com:2938325:0-krp-q4-2025-saw-record-production-higher-distributions-and-a-robust-outlook-for-2026/",
            "pub_date": "2026-02-27 01:08:45",
            "source": "Quartr",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "urn:summary_document_transcript:quartr.com:2938327:0",
            "title": "BALL: Operational excellence, disciplined capital allocation, and strong demand drive profitable growth",
            "description": "<div class=\"body-KX2tCBZq body-nzzZVyQ3 content-nzzZVyQ3\"><div class=\"symbolsContainer-uFduEtAF logosContainer-diQOvrPB\" data-no-swipe=\"true\"></div><div><span><p class=\"\"><span>Management is executing a four-pillar strategy focused on operational excellence, customer proximity, and profitable growth, with strong regional performance and early demand from major events. Financial discipline is maintained through strict capital allocation, targeted leverage, and robust forward contract coverage.</span></p><p class=\"\"><span>Based on </span></p><section class=\"variant-secondary-aHOVUrmQ disclaimer-fdvjGD1u\"><b class=\"heading-wrapper-aHOVUrmQ\"><span class=\"heading-aHOVUrmQ\">Disclaimer</span></b><div class=\"content-aHOVUrmQ link-with-underline-aHOVUrmQ\"><span>This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.</span></div></section></span></div></div>",
            "link": "https://www.tradingview.com/news/urn:summary_document_transcript:quartr.com:2938327:0-ball-operational-excellence-disciplined-capital-allocation-and-strong-demand-drive-profitable-growth/",
            "pub_date": "2026-02-27 01:08:48",
            "source": "Quartr",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "tag:reuters.com,2026-02-26:newsml_RSZ5979Ua:0",
            "title": "REG - MonEuroSmllCosTst - Transaction in Own Shares",
            "description": "<div class=\"body-KX2tCBZq body-nzzZVyQ3 content-nzzZVyQ3\"><div class=\"symbolsContainer-uFduEtAF logosContainer-diQOvrPB\" data-no-swipe=\"true\"></div><div><span><span>RNS Number : 5979U  Montanaro European Smaller C.TstPLC  26 February 2026   </span><ul class=\"list-bmN0_SHH list--padded-bmN0_SHH\"><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>Montanaro European Smaller Companies Trust PLC ('the Company')</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>LEI: 213800CWSC5B8BG3RS21</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>Transaction in Own Shares</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>In accordance with the Financial Conduct Authority's ('FCA') Disclosure Guidance and Transparency Rules, the Company announces that it has today purchased 115,148 of its own ordinary shares of 5p each at a price of 165.30p per share. These shares will be held in Treasury.</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>Following this transaction, the Company's share capital comprises:</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>Total issued share capital: 189,427,600</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>Shares held in Treasury (with no voting rights): 59,330,012</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>Total voting rights: 130,097,588</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>The total voting rights figure of 130,097,588 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>For further information, please contact:</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>Juniper Partners Limited</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>Company Secretary</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>email: cosec@junipartners.com</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>Telephone: 0131 378 0500</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>26 February 2026</span></p></li></ul><span>This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.</span><p class=\"\"><span>RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.   END  POSAKABKOBKDABB</span></p></span></div></div>",
            "link": "https://www.tradingview.com/news/reuters.com,2026-02-26:newsml_RSZ5979Ua:0-reg-moneurosmllcostst-transaction-in-own-shares/",
            "pub_date": "2026-02-27 01:08:53",
            "source": "London Stock Exchange",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "DJN_DN20260226012159_20260226012290:0",
            "title": "Valeo Sees Oper Margin From 4.7% to 5.3% in 2026",
            "description": "<div class=\"body-KX2tCBZq body-nzzZVyQ3 content-nzzZVyQ3\"><div class=\"symbolsContainer-uFduEtAF logosContainer-diQOvrPB\" data-no-swipe=\"true\"></div><div><span class=\"placeholder-diQOvrPB\">This news item displays a headline only and has no other text.</span></div></div>",
            "link": "https://www.tradingview.com/news/DJN_DN20260226012159_20260226012290:0/",
            "pub_date": "2026-02-27 01:09:00",
            "source": "Dow Jones Newswires",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "DJN_DN20260226012159_20260226012293:0",
            "title": "Valeo Expects Free Cash Flow of More than EUR400M in 2026",
            "description": "<div class=\"body-KX2tCBZq body-nzzZVyQ3 content-nzzZVyQ3\"><div class=\"symbolsContainer-uFduEtAF logosContainer-diQOvrPB\" data-no-swipe=\"true\"></div><div><span class=\"placeholder-diQOvrPB\">This news item displays a headline only and has no other text.</span></div></div>",
            "link": "https://www.tradingview.com/news/DJN_DN20260226012159_20260226012293:0/",
            "pub_date": "2026-02-27 01:09:00",
            "source": "Dow Jones Newswires",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "DJN_DN20260226012280_20260226012292:0",
            "title": "Raiffeisen Bank: Mandate Extended by Five Years From Nov 1",
            "description": "<div class=\"body-KX2tCBZq body-nzzZVyQ3 content-nzzZVyQ3\"><div class=\"symbolsContainer-uFduEtAF logosContainer-diQOvrPB\" data-no-swipe=\"true\"></div><div><span class=\"placeholder-diQOvrPB\">This news item displays a headline only and has no other text.</span></div></div>",
            "link": "https://www.tradingview.com/news/DJN_DN20260226012280_20260226012292:0/",
            "pub_date": "2026-02-27 01:09:00",
            "source": "Dow Jones Newswires",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "tag:reuters.com,2026-02-26:newsml_EM3KwtpCa:0",
            "title": "mBank Spółka Akcyjna - English version of mBank Group Consolidated Annual Report for the 12-month period ending 31 December 2025",
            "description": "<div class=\"body-KX2tCBZq body-nzzZVyQ3 content-nzzZVyQ3\"><div class=\"symbolsContainer-uFduEtAF logosContainer-diQOvrPB\" data-no-swipe=\"true\"></div><div><span><p class=\"\"><span>POLISH FINANCIAL SUPERVISION AUTHORITY</span></p><p class=\"\"><span>UNI - EN REPORT No 2 / 2026</span></p><p class=\"\"><span>Date of issue: 2026-02-26</span></p><p class=\"\"><span>Short name of the issuer</span></p><p class=\"\"><span>mBank S.A.</span></p><p class=\"\"><span>Subject</span></p><p class=\"\"><span>English version of mBank Group Consolidated Annual Report for the 12-month period ending 31</span></p><p class=\"\"><span>December 2025</span></p><p class=\"\"><span>Official market - legal basis</span></p><p class=\"\"><span>Art. 56. 1. 2 of Act on Public Offering</span></p><p class=\"\"><span>Unofficial market - legal basis</span></p><p class=\"\"><span>/-/</span></p><p class=\"\"><span>Contents of the report:</span></p><p class=\"\"><span>mBank Independent Auditor Report Consolidated 2025;</span></p><p class=\"\"><span>Letter of the President of the Management Board to the Shareholders;</span></p><p class=\"\"><span>Letter of the Chairwoman of the Supervisory Board to the Shareholders;</span></p><p class=\"\"><span>Opinion of the Supervisory Board of mBank S.A. on the situation of the Group 2025;</span></p><p class=\"\"><span>Opinion of Supervisory Board on Financial Statements 2025;</span></p><p class=\"\"><span>Statements of the Supervisory Board with respect to the Audit Committee;</span></p><p class=\"\"><span>The Management Board Information on the selection of an audit firm to audit the Financial</span></p><p class=\"\"><span>Statements;</span></p><p class=\"\"><span>The Management Board Information on the selection of an audit firm to attest the Sustainability</span></p><p class=\"\"><span>Statement;</span></p><p class=\"\"><span>mBank Group Consolidated Financial Statement YE 2025;</span></p><p class=\"\"><span>mBank S.A. Group Management Board Report 2025;</span></p><p class=\"\"><span>Independent Auditor's Assurance Report on the Sustainability Statement 2025.</span></p><p class=\"\"><span>Annexes</span></p><p class=\"\"><span>File Description</span></p><p class=\"\"><span>Additional attachments can be found below:</span></p><p class=\"\"><span>20260226_180900_2142964885_EN_Sprawozdanie_BR_z_atestacji_SZR_mBank_2025.xhtml</span></p><p class=\"\"><a class=\"link-zw5jRdec icon-zw5jRdec\" href=\"https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260226:nEM66jdcna\" rel=\"nofollow\" target=\"_blank\">newsfile.refinitiv.com/getnewsfile/v1/story</a></p><p class=\"\"><span>20260226_180900_2142964885_esef_mBank_SSF-2025-12-31-1-en.zip</span></p><p class=\"\"><a class=\"link-zw5jRdec icon-zw5jRdec\" href=\"https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260226:nEM6S78vqa\" rel=\"nofollow\" target=\"_blank\">newsfile.refinitiv.com/getnewsfile/v1/story</a></p><p class=\"\"><span>20260226_180900_2142964885_mBank-ListCEO-2025-12-31-1-en.xhtml</span></p><p class=\"\"><a class=\"link-zw5jRdec icon-zw5jRdec\" href=\"https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260226:nEM6ftB5ra\" rel=\"nofollow\" target=\"_blank\">newsfile.refinitiv.com/getnewsfile/v1/story</a></p><p class=\"\"><span>20260226_180900_2142964885_mBank-ListPRN-2025-12-31-1-en.xhtml</span></p><p class=\"\"><a class=\"link-zw5jRdec icon-zw5jRdec\" href=\"https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260226:nEMkmsKXa\" rel=\"nofollow\" target=\"_blank\">newsfile.refinitiv.com/getnewsfile/v1/story</a></p><p class=\"\"><span>20260226_180900_2142964885_mBank-OcenaRN-2025-12-31-1-en.xhtml</span></p><p class=\"\"><a class=\"link-zw5jRdec icon-zw5jRdec\" href=\"https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260226:nEM8L78jGa\" rel=\"nofollow\" target=\"_blank\">newsfile.refinitiv.com/getnewsfile/v1/story</a></p><p class=\"\"><span>20260226_180900_2142964885_mBank-RN-OswKA-2025-12-31-1-en.xhtml</span></p><p class=\"\"><a class=\"link-zw5jRdec icon-zw5jRdec\" href=\"https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260226:nEM485w65a\" rel=\"nofollow\" target=\"_blank\">newsfile.refinitiv.com/getnewsfile/v1/story</a></p><p class=\"\"><span>20260226_180900_2142964885_mBank-RNOcenaSpr-2025-12-31-1-en.xhtml</span></p><p class=\"\"><a class=\"link-zw5jRdec icon-zw5jRdec\" href=\"https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260226:nEM7nzDgta\" rel=\"nofollow\" target=\"_blank\">newsfile.refinitiv.com/getnewsfile/v1/story</a></p><p class=\"\"><span>20260226_180900_2142964885_mBank-ZBAudytor-2025-12-31-1-en.xhtml</span></p><p class=\"\"><a class=\"link-zw5jRdec icon-zw5jRdec\" href=\"https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260226:nEM1CLQMHa\" rel=\"nofollow\" target=\"_blank\">newsfile.refinitiv.com/getnewsfile/v1/story</a></p><p class=\"\"><span>20260226_180900_2142964885_mBank-ZBAudytorSZR-2025-12-31-1-en.xhtml</span></p><p class=\"\"><a class=\"link-zw5jRdec icon-zw5jRdec\" href=\"https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260226:nEM3llc3Ba\" rel=\"nofollow\" target=\"_blank\">newsfile.refinitiv.com/getnewsfile/v1/story</a></p><p class=\"\"><span>20260226_180900_2142964885_mBank_B044AY_Sprawozdanie_z_badania_SSF_31122025_ENG_FINAL.xhtml</span></p><p class=\"\"><a class=\"link-zw5jRdec icon-zw5jRdec\" href=\"https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260226:nEM5Ytts3a\" rel=\"nofollow\" target=\"_blank\">newsfile.refinitiv.com/getnewsfile/v1/story</a></p><p class=\"\"><span>20260226_180900_2142964885_mBank_SDZ-2025-12-31-1-en.xhtml</span></p><p class=\"\"><a class=\"link-zw5jRdec icon-zw5jRdec\" href=\"https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260226:nEM86LZwha\" rel=\"nofollow\" target=\"_blank\">newsfile.refinitiv.com/getnewsfile/v1/story</a></p></span></div></div>",
            "link": "https://www.tradingview.com/news/reuters.com,2026-02-26:newsml_EM3KwtpCa:0-mbank-sp-ka-akcyjna-english-version-of-mbank-group-consolidated-annual-report-for-the-12-month-period-ending-31-december-2025/",
            "pub_date": "2026-02-27 01:09:13",
            "source": "Polish Emitent",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "stocktwits:bc146a469094b:0",
            "title": "AKBA Shares Rise On Clinical Pipeline Optimism As Anemia Drug Gains Traction",
            "description": "<div class=\"body-KX2tCBZq body-nzzZVyQ3 content-nzzZVyQ3\"><div class=\"symbolsContainer-uFduEtAF logosContainer-diQOvrPB\" data-no-swipe=\"true\"></div><div><div class=\"summary-diQOvrPB\"><div class=\"summaryTitle-diQOvrPB\">Key points:</div><span><ul class=\"list-bmN0_SHH\"><li class=\"listItem-bmN0_SHH listItem--lightning-bmN0_SHH\"><span>Enrollment is also underway for the company’s study of its other experimental therapy praliciguat in focal segmental glomerulosclerosis (FSGS).</span></li><li class=\"listItem-bmN0_SHH listItem--lightning-bmN0_SHH\"><span>In 2026, the company expects a significant revenue growth for Vafseo through expanded access to therapy at dialysis organizations, new patient starts, and improved adherence rates.</span></li><li class=\"listItem-bmN0_SHH listItem--lightning-bmN0_SHH\"><span>The company ended Q4 with cash and cash equivalents of about $184.8 million, which it expects to be sufficient to fund current operating plan for at least two years.</span></li></ul></span></div><span><p class=\"\"><span>Shares of Akebia Therapeutics Inc (AKBA) rose 7% on Thursday after the company announced that it expects significant revenue growth for its approved anemia medicine Vafseo in 2026 while it also advances its clinical pipeline.</span></p><p class=\"\"><span>The company said on Thursday that it now expects its mid-stage trial of AKB-097 in rare kidney diseases to start in the second half of 2026, with initial data expected in 2027. Akebia acquired the experimental drug from Q32 Bio in November. The company will explore the drug in IgA nephropathy, lupus nephritis and C3 glomerulopathy, it said.</span></p><p class=\"\"><span>Enrollment is also underway for the company’s study of its other experimental therapy praliciguat in focal segmental glomerulosclerosis (FSGS). Target enrollment for the trial is approximately 60 patients.</span></p><p class=\"\"><strong class=\"root-Tkn6WL2y\"><span>Future Of FDA-Approved Medicines</span></strong></p><p class=\"\"><span>Akebia has two medicines approved by the U.S. Food and Drug Administration including </span><a class=\"link-zw5jRdec icon-zw5jRdec\" href=\"https://stocktwits.com/news-articles/markets/equity/akebia-therapeutics-stock-slumps-after-fda-meeting-ends-without-path-forward-for-vafseo-label-expansion/cLGZtPhR3wx\" rel=\"nofollow\" target=\"_blank\">Vafseo </a><span>for the treatment of anemia due to chronic kidney disease (CKD) in dialysis patients. In 2026, the company expects a significant revenue growth for Vafseo through expanded access to therapy at dialysis organizations, new patient starts, and improved adherence rates.</span></p><p class=\"\"><span>“Vafseo commercial trends are showing marked improvement in early 2026... Patient access to Vafseo therapy now stands at 290,000 patients, and early data points to improved patient adherence rates, which we believe are enhanced as a result of dialysis organizations deciding to implement observed dosing protocols. These dynamics, along with the building evidence of clinical differentiation, are expected to drive significant Vafseo revenue growth in 2026 and beyond…, ” said CEO John P. Butler.</span></p><p class=\"\"><strong class=\"root-Tkn6WL2y\"><span>Q4 Numbers</span></strong></p><p class=\"\"><span>For the fourth quarter, the company reported net product revenues of $54.3 million, owing to a quarter-on-quarter increase in prescribers for Vafseo which was launched in the U.S. in Jan. 2025 and an increase in sales volume for Auryxia. Analysts on average were expecting the company to report revenue of $46.09 million.</span></p><p class=\"\"><span>Net loss per share for the period came in at $0.05, compared to a loss of $0.10 in the corresponding quarter of 2024, but above an analyst estimate of a loss of $0.04.</span></p><p class=\"\"><span>The company ended the quarter with cash and cash equivalents of about $184.8 million, which it expects to be sufficient to fund current operating plan for at least two years.</span></p><p class=\"\"><strong class=\"root-Tkn6WL2y\"><span>How Did Stocktwits Users React?</span></strong></p><p class=\"\"><span>On Stocktwits, retail sentiment around AKBA stock rose from ‘neutral’ to ‘bullish’ territory over the past 24 hours, while message volume remained at ‘high’ levels.</span></p><p class=\"\"><span>A Stocktwits user highlighted the several potential catalysts for the stock including accelerating adoption for Vafseo and cash hoard.</span></p><p class=\"\"><span>https://www.stocktwits.com/ROCKET123/message/645988666</span></p><p class=\"\"><span>Another voiced hopes for stock as much as doubling “sooner or later.”</span></p><p class=\"\"><span>https://www.stocktwits.com/Andi77/message/645980832</span></p><p class=\"\"><a class=\"link-zw5jRdec icon-zw5jRdec\" href=\"https://stocktwits.com/symbol/AKBA\" rel=\"nofollow\" target=\"_blank\">AKBA stock</a><span> has fallen 28% over the past 12 months. </span></p></span></div></div>",
            "link": "https://www.tradingview.com/news/stocktwits:bc146a469094b:0/",
            "pub_date": "2026-02-27 01:09:31",
            "source": "Stocktwits",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "DJN_DN20260226012280_20260226012306:0",
            "title": "Raiffeisen Bank: She Has Been Management Board Member Since Nov 2023",
            "description": "<div class=\"body-KX2tCBZq body-nzzZVyQ3 content-nzzZVyQ3\"><div class=\"symbolsContainer-uFduEtAF logosContainer-diQOvrPB\" data-no-swipe=\"true\"></div><div><span class=\"placeholder-diQOvrPB\">This news item displays a headline only and has no other text.</span></div></div>",
            "link": "https://www.tradingview.com/news/DJN_DN20260226012280_20260226012306:0/",
            "pub_date": "2026-02-27 01:10:00",
            "source": "Dow Jones Newswires",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "tag:reuters.com,2026:newsml_L1N3ZM14E:0",
            "title": "France's Bonduelle H1 revenue falls slightly",
            "description": "<div class=\"body-KX2tCBZq body-nzzZVyQ3 content-nzzZVyQ3\"><div class=\"symbolsContainer-uFduEtAF logosContainer-diQOvrPB\" data-no-swipe=\"true\"></div><div><span><p class=\"\"><span>Overview</span></p><ul class=\"list-bmN0_SHH list--padded-bmN0_SHH\"><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>French vegetable producer's H1 revenue declined 0.7% on reported figures, but rose 0.3% like-for-like</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>Net income from continuing operations increased by 18.5% yr/yr</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>Consolidated net income improved significantly due to salad business disposal</span></p></li></ul><p class=\"\"><span>Outlook</span></p><ul class=\"list-bmN0_SHH list--padded-bmN0_SHH\"><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>Bonduelle targets operating profitability of 80 mln euros for fiscal year ending June 2026</span></p></li></ul><p class=\"\"><span>Result Drivers</span></p><ul class=\"list-bmN0_SHH list--padded-bmN0_SHH\"><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>BRAND GROWTH - Growth of Cassegrain brand in France and Bonduelle brand in emerging markets contributed to sales</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>COST MANAGEMENT - Initiatives to improve industrial performance and manage costs supported operating income</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>DISPOSAL IMPACT - Disposal of loss-making salad business positively impacted net income</span></p></li></ul><p class=\"\"><span>Company press release: </span></p><p class=\"\"><span>Key Details</span></p><div class=\"tableContainer-VG8_37yK\"><table class=\"table-VG8_37yK\" data-no-swipe=\"true\"><tbody><tr><td><p class=\"\"><span>Metric</span></p></td><td><p class=\"\"><span>Beat/Miss</span></p></td><td><p class=\"\"><span>Actual</span></p></td><td><p class=\"\"><span>Consensus Estimate</span></p></td></tr><tr><td><p class=\"\"><span>H1 Revenue</span></p></td><td></td><td><p class=\"\"><span>EUR 1.11 bln</span></p></td><td></td></tr><tr><td><p class=\"\"><span>H1 Net Income</span></p></td><td></td><td><p class=\"\"><span>EUR 56.5 mln</span></p></td><td></td></tr><tr><td><p class=\"\"><span>H1 Current Operating Income</span></p></td><td></td><td><p class=\"\"><span>EUR 50.5 mln</span></p></td><td></td></tr><tr><td><p class=\"\"><span>H1 EBIT Margin</span></p></td><td></td><td><p class=\"\"><span>4.5%</span></p></td><td></td></tr></tbody></table></div><p class=\"\"><span>Analyst Coverage</span></p><ul class=\"list-bmN0_SHH list--padded-bmN0_SHH\"><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>The current average analyst rating on the shares is \"hold\" and the breakdown of recommendations is 1 \"strong buy\" or \"buy\", 4 \"hold\" and no \"sell\" or \"strong sell\"</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>The average consensus recommendation for the food processing peer group is \"buy.\"</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>Wall Street's median 12-month price target for Bonduelle SA is €9.30, about 6.9% below its February 25 closing price of €9.99</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>The stock recently traded at 7 times the next 12-month earnings vs. a P/E of 7 three months ago</span></p></li></ul><p class=\"\"><span>For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact </span><a class=\"link-zw5jRdec icon-zw5jRdec\" href=\"http://mailto:reuters.support@thomsonreuters.com\" rel=\"nofollow\" target=\"_blank\">reuters.support@thomsonreuters.com</a><span>.</span></p></span></div></div>",
            "link": "https://www.tradingview.com/news/reuters.com,2026:newsml_L1N3ZM14E:0-france-s-bonduelle-h1-revenue-falls-slightly/",
            "pub_date": "2026-02-27 01:10:05",
            "source": "Reuters",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "urn:summary_document_slides:quartr.com:2938336:0",
            "title": "GEST: Strong FY 2025 profitability and cash flow achieved amid market volatility and EV realignment",
            "description": "<div class=\"body-KX2tCBZq body-nzzZVyQ3 content-nzzZVyQ3\"><div class=\"symbolsContainer-uFduEtAF logosContainer-diQOvrPB\" data-no-swipe=\"true\"></div><div><span><p class=\"\"><span>FY 2025 saw strong profitability and record free cash flow despite revenue declines from forex and scrap prices. All targets were met, leverage hit a record low, and strategic actions realigned EV exposure. 2026 is expected to be flat, with focus on profitability and balance sheet strength.</span></p><p class=\"\"><span>Original document: </span><a class=\"link-zw5jRdec\" href=\"https://www.tradingview.com/accounts/signin?next=https%3A%2F%2Fnews-mediator.tradingview.com%2Fdoc-screener%2Fv1%2Ffiles%2Furn%3Aslides%3Aquartr.com%3A2938336-1b784d54191ece548e87d0897aae865c\" target=\"_blank\">Gestamp Automocion S.A. [GEST] Slides Release — Feb. 26 2026</a></p><section class=\"variant-secondary-aHOVUrmQ disclaimer-fdvjGD1u\"><b class=\"heading-wrapper-aHOVUrmQ\"><span class=\"heading-aHOVUrmQ\">Disclaimer</span></b><div class=\"content-aHOVUrmQ link-with-underline-aHOVUrmQ\"><span>This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.</span></div></section></span></div></div>",
            "link": "https://www.tradingview.com/news/urn:summary_document_slides:quartr.com:2938336:0-gest-strong-fy-2025-profitability-and-cash-flow-achieved-amid-market-volatility-and-ev-realignment/",
            "pub_date": "2026-02-27 01:10:35",
            "source": "Quartr",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "urn:summary_document_transcript:quartr.com:2938291:0",
            "title": "NWPX: Record financials, strong backlog, and strategic growth position for a robust 2026",
            "description": "<div class=\"body-KX2tCBZq body-nzzZVyQ3 content-nzzZVyQ3\"><div class=\"symbolsContainer-uFduEtAF logosContainer-diQOvrPB\" data-no-swipe=\"true\"></div><div><span><p class=\"\"><span>Record 2025 results featured strong revenue, margin expansion, and robust cash flow, driven by operational excellence and strategic growth in both WTS and Precast segments. The company enters 2026 with a strong backlog, healthy order books, and continued focus on organic growth and disciplined capital allocation.</span></p><p class=\"\"><span>Based on </span></p><section class=\"variant-secondary-aHOVUrmQ disclaimer-fdvjGD1u\"><b class=\"heading-wrapper-aHOVUrmQ\"><span class=\"heading-aHOVUrmQ\">Disclaimer</span></b><div class=\"content-aHOVUrmQ link-with-underline-aHOVUrmQ\"><span>This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.</span></div></section></span></div></div>",
            "link": "https://www.tradingview.com/news/urn:summary_document_transcript:quartr.com:2938291:0-nwpx-record-financials-strong-backlog-and-strategic-growth-position-for-a-robust-2026/",
            "pub_date": "2026-02-27 01:03:16",
            "source": "Quartr",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "urn:summary_document_transcript:quartr.com:2938292:0",
            "title": "HTO: Raised long-term EPS growth target to 6–8% CAGR, driven by record CapEx and Texas expansion",
            "description": "<div class=\"body-KX2tCBZq body-nzzZVyQ3 content-nzzZVyQ3\"><div class=\"symbolsContainer-uFduEtAF logosContainer-diQOvrPB\" data-no-swipe=\"true\"></div><div><span><p class=\"\"><span>Reported strong 2025 results with adjusted EPS of $2.99, record CapEx, and a 31% increase in the five-year CapEx plan. Raised long-term EPS growth target to 6–8% CAGR, with Quadvest acquisition set to drive significant Texas expansion and future earnings accretion.</span></p><p class=\"\"><span>Based on </span></p><section class=\"variant-secondary-aHOVUrmQ disclaimer-fdvjGD1u\"><b class=\"heading-wrapper-aHOVUrmQ\"><span class=\"heading-aHOVUrmQ\">Disclaimer</span></b><div class=\"content-aHOVUrmQ link-with-underline-aHOVUrmQ\"><span>This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.</span></div></section></span></div></div>",
            "link": "https://www.tradingview.com/news/urn:summary_document_transcript:quartr.com:2938292:0-hto-raised-long-term-eps-growth-target-to-6-8-cagr-driven-by-record-capex-and-texas-expansion/",
            "pub_date": "2026-02-27 01:03:17",
            "source": "Quartr",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "urn:summary_document_transcript:quartr.com:2938293:0",
            "title": "AMSF: Strong premium growth, high retention, and robust capital offset higher claim severity in 2025",
            "description": "<div class=\"body-KX2tCBZq body-nzzZVyQ3 content-nzzZVyQ3\"><div class=\"symbolsContainer-uFduEtAF logosContainer-diQOvrPB\" data-no-swipe=\"true\"></div><div><span><p class=\"\"><span>ROE reached 18.5% and combined ratio was 91.3% in 2025, with strong premium growth and retention. Loss ratio rose to 72% due to higher claim severity, but growth is broad-based and sustainable. Capital position remains robust.</span></p><p class=\"\"><span>Based on </span></p><section class=\"variant-secondary-aHOVUrmQ disclaimer-fdvjGD1u\"><b class=\"heading-wrapper-aHOVUrmQ\"><span class=\"heading-aHOVUrmQ\">Disclaimer</span></b><div class=\"content-aHOVUrmQ link-with-underline-aHOVUrmQ\"><span>This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.</span></div></section></span></div></div>",
            "link": "https://www.tradingview.com/news/urn:summary_document_transcript:quartr.com:2938293:0-amsf-strong-premium-growth-high-retention-and-robust-capital-offset-higher-claim-severity-in-2025/",
            "pub_date": "2026-02-27 01:03:18",
            "source": "Quartr",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "urn:summary_document_transcript:quartr.com:2938294:0",
            "title": "IBP: Record profitability and strong commercial growth offset residential softness, supporting a positive 2026 outlook",
            "description": "<div class=\"body-KX2tCBZq body-nzzZVyQ3 content-nzzZVyQ3\"><div class=\"symbolsContainer-uFduEtAF logosContainer-diQOvrPB\" data-no-swipe=\"true\"></div><div><span><p class=\"\"><span>Record sales and profitability in 2025 were driven by strong commercial performance and disciplined capital allocation, offsetting residential market headwinds. Heavy commercial and complementary products fueled margin expansion, while a robust acquisition pipeline and healthy backlogs support a positive 2026 outlook.</span></p><p class=\"\"><span>Based on </span></p><section class=\"variant-secondary-aHOVUrmQ disclaimer-fdvjGD1u\"><b class=\"heading-wrapper-aHOVUrmQ\"><span class=\"heading-aHOVUrmQ\">Disclaimer</span></b><div class=\"content-aHOVUrmQ link-with-underline-aHOVUrmQ\"><span>This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.</span></div></section></span></div></div>",
            "link": "https://www.tradingview.com/news/urn:summary_document_transcript:quartr.com:2938294:0-ibp-record-profitability-and-strong-commercial-growth-offset-residential-softness-supporting-a-positive-2026-outlook/",
            "pub_date": "2026-02-27 01:03:20",
            "source": "Quartr",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "urn:summary_document_transcript:quartr.com:2938295:0",
            "title": "GDRX: Pharma Direct revenue surged 41% in 2025, driving growth amid evolving healthcare trends",
            "description": "<div class=\"body-KX2tCBZq body-nzzZVyQ3 content-nzzZVyQ3\"><div class=\"symbolsContainer-uFduEtAF logosContainer-diQOvrPB\" data-no-swipe=\"true\"></div><div><span><p class=\"\"><span>Q4 and full-year 2025 results showed stable revenue and EBITDA growth, with Pharma Direct revenue up 41% year-over-year and new subscription offerings gaining traction. 2026 guidance reflects near-term revenue pressure from strategic investments, but long-term growth is expected as Pharma Direct and subscriptions scale.</span></p><p class=\"\"><span>Based on </span></p><section class=\"variant-secondary-aHOVUrmQ disclaimer-fdvjGD1u\"><b class=\"heading-wrapper-aHOVUrmQ\"><span class=\"heading-aHOVUrmQ\">Disclaimer</span></b><div class=\"content-aHOVUrmQ link-with-underline-aHOVUrmQ\"><span>This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.</span></div></section></span></div></div>",
            "link": "https://www.tradingview.com/news/urn:summary_document_transcript:quartr.com:2938295:0-gdrx-pharma-direct-revenue-surged-41-in-2025-driving-growth-amid-evolving-healthcare-trends/",
            "pub_date": "2026-02-27 01:03:21",
            "source": "Quartr",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "tag:reuters.com,2026:newsml_L1N3ZM100:0",
            "title": "Setback for Meta as court adviser backs EU regulators in data spat",
            "description": "<div class=\"body-KX2tCBZq body-nzzZVyQ3 content-nzzZVyQ3\"><div class=\"symbolsContainer-uFduEtAF logosContainer-diQOvrPB\" data-no-swipe=\"true\"></div><div><span><p class=\"\"><span>By Foo Yun Chee and Charlotte Van Campenhout</span></p><p class=\"\"><span>An adviser to Europe's top court on Thursday sided with EU regulators demanding information regarding two antitrust investigations of Meta Platforms </span><span>, in a setback for the U.S.-based social media company.</span></p><p class=\"\"><span>     The case underscores the increasing tendency by companies to challenge the EU antitrust enforcer over what they say are disproportionate regulatory demands. </span></p><p class=\"\"><span>Meta had taken its case to the Luxembourg-based Court of Justice of the European Union, questioning EU demands related to its Facebook social network and online classified ads.</span></p><p class=\"\"><span>The court's Advocate General Athanasios Rantos said judges should dismiss Meta's appeal and uphold a lower tribunal's ruling that backed the European Commission, the EU's competition enforcer.</span></p><p class=\"\"><span>\"The Commission has broad powers of investigation which enable it to request all necessary information in order to carry out its tasks,\" he said in a non-binding opinion.</span></p><p class=\"\"><span>\"The documents referred to by the applicant did not contain sensitive data and the Commission's access was subject to strict limits and safeguards, with no disproportionate interference with privacy,\" Rantos said.</span></p><p class=\"\"><span>Judges, who tend to follow the majority of such recommendations, will rule in the coming months.</span></p><p class=\"\"><span>Meta had complained that EU demands included documents such as autopsy reports on family members, children's school reports, information about individuals and their families, and even security details.</span></p><p class=\"\"><span>While Meta's judicial challenge against the EU regulatory information demands was going on, regulators ended their investigation in 2024 by levying a 797.7 million euro ($941 million) fine.</span></p><p class=\"\"><span>The violations related to Meta tying its Facebook Marketplace online classified ads service to its personal social network Facebook and imposing unfair trading conditions on other online classified ads service providers.</span></p><p class=\"\"><span>The cases are C-496/23 P Meta Platforms Ireland v Commission (Facebook Marketplace) and C-497/23 P Meta Platforms Ireland v Commission (Facebook Data).</span></p><p class=\"\"><span>($1 = 0.8477 euros)</span></p></span></div></div>",
            "link": "https://www.tradingview.com/news/reuters.com,2026:newsml_L1N3ZM100:0-setback-for-meta-as-court-adviser-backs-eu-regulators-in-data-spat/",
            "pub_date": "2026-02-27 01:03:30",
            "source": "Reuters",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "tag:reuters.com,2026-02-26:newsml_RSZ5984Ua:0",
            "title": "REG - JPMorgan Amer InvTst - Transaction in Own Shares",
            "description": "<div class=\"body-KX2tCBZq body-nzzZVyQ3 content-nzzZVyQ3\"><div class=\"symbolsContainer-uFduEtAF logosContainer-diQOvrPB\" data-no-swipe=\"true\"></div><div><span><span>RNS Number : 5984U  JPMorgan American IT PLC  26 February 2026   </span><p class=\"\"><span>LONDON STOCK EXCHANGE ANNOUNCEMENT</span></p><p class=\"\"><span>JPMORGAN AMERICAN INVESTMENT TRUST PLC</span></p><p class=\"\"><span>(the 'Company')</span></p><p class=\"\"><span>REPURCHASE OF ORDINARY SHARES INTO TREASURY</span></p><p class=\"\"><span>Legal Entity Identifier: 549300QNAI4XRPEB4G65</span></p><p class=\"\"><span>The Company announces that it repurchased 50,000 Ordinary Shares into Treasury at 1129.70 pence per share.</span></p><p class=\"\"><span>Following the transaction, the Company holds 112,994,025 shares in Treasury. The shares in issue less the total number of Treasury shares is 168,639,885. The Company will only re-issue shares held in Treasury at a premium to net asset value.</span></p><p class=\"\"><span>26th February 2026</span></p><p class=\"\"><span>For further information, please contact:</span></p><p class=\"\"><span>Divya Amin</span></p><p class=\"\"><span>JPMorgan Funds Limited</span></p><p class=\"\"><span>Company Secretary </span></p><p class=\"\"><span>0800 20 40 20 (or +44 1268 44 44 70)</span></p><span>This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.</span><p class=\"\"><span>RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.   END  POSDQLFLQLLBBBL</span></p></span></div></div>",
            "link": "https://www.tradingview.com/news/reuters.com,2026-02-26:newsml_RSZ5984Ua:0-reg-jpmorgan-amer-invtst-transaction-in-own-shares/",
            "pub_date": "2026-02-27 01:03:44",
            "source": "London Stock Exchange",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "DJN_DN20260226012159_20260226012172:0",
            "title": "Valeo 2025 Net Pft EUR200M",
            "description": "<div class=\"body-KX2tCBZq body-nzzZVyQ3 content-nzzZVyQ3\"><div class=\"symbolsContainer-uFduEtAF logosContainer-diQOvrPB\" data-no-swipe=\"true\"></div><div><span class=\"placeholder-diQOvrPB\">This news item displays a headline only and has no other text.</span></div></div>",
            "link": "https://www.tradingview.com/news/DJN_DN20260226012159_20260226012172:0/",
            "pub_date": "2026-02-27 01:04:00",
            "source": "Dow Jones Newswires",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "DJN_DN20260226012175:0",
            "title": "Netflix Still Seen Winning out Over Paramount in Warner Bros. Bidding War — Market Talk",
            "description": "<div class=\"body-KX2tCBZq body-nzzZVyQ3 content-nzzZVyQ3\"><div class=\"symbolsContainer-uFduEtAF logosContainer-diQOvrPB\" data-no-swipe=\"true\"></div><div><span><p class=\"\"><span>Netflix is still more likely than not to succeed in its bid for Warner Bros. Discovery's streaming and studio businesses, Neuberger Berman's Sean Badcock says. Earlier this week, Warner's board said an improved bid from rival Paramount Skydance \"could reasonably be expected to lead\" to a proposal superior to Netflix's signed agreement. However, a further bid from the streaming giant is expected, Badcock says. Moreover, it isn't clear that Paramount will be able to return with a higher offer, Badcock adds. \"They seem to have passed the ability to pay, but they don't seem to have run out of willingness to pay.\" (josephmichael.stonor@wsj.com)</span></p></span></div></div>",
            "link": "https://www.tradingview.com/news/DJN_DN20260226012175:0/",
            "pub_date": "2026-02-27 01:04:00",
            "source": "Dow Jones Newswires",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "stocktwits:c653d7c22094b:0",
            "title": "Google Launches Nano Banana 2 With Faster Performance And Advanced Reasoning As AI Race Heats Up",
            "description": "<div class=\"body-KX2tCBZq body-nzzZVyQ3 content-nzzZVyQ3\"><div class=\"symbolsContainer-uFduEtAF logosContainer-diQOvrPB\" data-no-swipe=\"true\"></div><div><div class=\"summary-diQOvrPB\"><div class=\"summaryTitle-diQOvrPB\">Key points:</div><span><ul class=\"list-bmN0_SHH\"><li class=\"listItem-bmN0_SHH listItem--lightning-bmN0_SHH\"><span>Google said the updated system taps into Gemini’s broader knowledge framework and integrates real-time information from web search.</span></li><li class=\"listItem-bmN0_SHH listItem--lightning-bmN0_SHH\"><span>The tool can generate infographics, transform written notes into diagrams, and produce data visualizations.</span></li><li class=\"listItem-bmN0_SHH listItem--lightning-bmN0_SHH\"><span>Google is deploying Nano Banana 2 across several services, including the Gemini app and Search.</span></li></ul></span></div><span><p class=\"\"><span>Alphabet Inc. (GOOG, GOOGL) on Tuesday unveiled Nano Banana 2, expanding its artificial intelligence image-generation lineup and aiming to blend high-speed performance with advanced reasoning. </span></p><p class=\"\"><span>The new release arrives roughly six months after the company debuted the original Nano Banana, a product that quickly gained widespread attention and positioned Google more directly against OpenAI.</span></p><p class=\"\"><strong class=\"root-Tkn6WL2y\"><span>Faster Performance Meets Deeper Knowledge</span></strong></p><p class=\"\"><span>Google said the updated system taps into Gemini’s broader knowledge framework and integrates real-time information from web search to improve its rendering of detailed subjects. The tool can generate infographics, transform written notes into diagrams, and produce data visualizations with improved contextual accuracy.</span></p><p class=\"\"><span>The company also highlighted upgrades in text clarity within images. Users can create readable marketing materials and translate embedded text into different languages.</span></p><p class=\"\"><a class=\"link-zw5jRdec icon-zw5jRdec\" href=\"https://stocktwits.com/symbol/GOOGL\" rel=\"nofollow\" target=\"_blank\">Alphabet Class A stock</a><span> traded over 2% lower on Thursday mid-morning. On Stocktwits, retail sentiment around the stock remained in ‘bearish’ territory amid ‘low’ message volume levels. </span></p><p class=\"\"><strong class=\"root-Tkn6WL2y\"><span>Broad Rollout Across Google Platforms</span></strong></p><p class=\"\"><span>Google is deploying Nano Banana 2 across several services, including the Gemini app, Search, AI Studio, and its Gemini API within Vertex AI. The model will also power creative tools in Google Ads and become the default image generator in Flow. Subscribers to Google AI Pro and Ultra will continue to access the earlier Pro model for tasks requiring heightened factual precision.</span></p><p class=\"\"><span>The updated version will be powered by Gemini 3.1. Since launching Gemini 3, Google has surged to the forefront of artificial intelligence innovation, strengthening its position among the top AI developers.</span></p><p class=\"\"><span>The launch underscores Google’s efforts to keep pace with rivals such as Microsoft Corp. (MSFT), which has deepened its partnership with OpenAI, and Meta Platforms Inc. (NASDAQ: META), which continues investing heavily in AI research. </span></p><p class=\"\"><span>GOOGL stock has gained by over 77% in the last 12 months. </span></p></span></div></div>",
            "link": "https://www.tradingview.com/news/stocktwits:c653d7c22094b:0/",
            "pub_date": "2026-02-27 01:04:03",
            "source": "Stocktwits",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "tag:reuters.com,2026:newsml_FWN3ZM26F:0",
            "title": "Bookrunner Says Wizz Air Secondary ABO Books Covered, Further Guidance To Follow",
            "description": "<div class=\"body-KX2tCBZq body-nzzZVyQ3 content-nzzZVyQ3\"><div class=\"symbolsContainer-uFduEtAF logosContainer-diQOvrPB\" data-no-swipe=\"true\"></div><div><span><p class=\"\"><span>Bookrunner:</span></p><ul class=\"list-bmN0_SHH list--padded-bmN0_SHH\"><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>BLOCK TRADE: WIZZ AIR SECONDARY ABO BOOKS COVERED FURTHER GUIDANCE TO FOLLOW - BOOKRUNNER</span></p></li></ul></span></div></div>",
            "link": "https://www.tradingview.com/news/reuters.com,2026:newsml_FWN3ZM26F:0-bookrunner-says-wizz-air-secondary-abo-books-covered-further-guidance-to-follow/",
            "pub_date": "2026-02-27 01:04:37",
            "source": "Reuters",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "DJN_DN20260226012159_20260226012218:0",
            "title": "Valeo 2025 Oper Pft EUR977M",
            "description": "<div class=\"body-KX2tCBZq body-nzzZVyQ3 content-nzzZVyQ3\"><div class=\"symbolsContainer-uFduEtAF logosContainer-diQOvrPB\" data-no-swipe=\"true\"></div><div><span class=\"placeholder-diQOvrPB\">This news item displays a headline only and has no other text.</span></div></div>",
            "link": "https://www.tradingview.com/news/DJN_DN20260226012159_20260226012218:0/",
            "pub_date": "2026-02-27 01:05:00",
            "source": "Dow Jones Newswires",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "tag:reuters.com,2026:newsml_PLX9AC334:0",
            "title": "SMCP Eyes Around 10% Adjusted EBIT Margin In H2 2026",
            "description": "<div class=\"body-KX2tCBZq body-nzzZVyQ3 content-nzzZVyQ3\"><div class=\"symbolsContainer-uFduEtAF logosContainer-diQOvrPB\" data-no-swipe=\"true\"></div><div><span><p class=\"\"><span>SMCP SA </span><span>:</span></p><ul class=\"list-bmN0_SHH list--padded-bmN0_SHH\"><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>SMCP FY SALES EUR 1,217.4 MILLION VERSUS IBES ESTIMATE EUR 1,228 MILLION</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>SMCP FY ADJUSTED EBIT EUR 95.2 MILLION</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>SMCP FY ADJUSTED EBITDA EUR 231.3 MILLION</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>SMCP FY FREE CASH FLOW EUR 91.1 MILLION</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>SMCP FY NET INCOME EUR 16.6 MILLION</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>OUTLOOK 2026: AROUND 10% ADJUSTED EBIT MARGIN IN H2 2026</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>OUTLOOK 2026: FREE CASH-FLOW GENERATION OF EUR 50 MILLION</span></p></li></ul></span></div></div>",
            "link": "https://www.tradingview.com/news/reuters.com,2026:newsml_PLX9AC334:0-smcp-eyes-around-10-adjusted-ebit-margin-in-h2-2026/",
            "pub_date": "2026-02-27 01:05:03",
            "source": "Reuters",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "DJN_DN20260226011966_20260226011980:0",
            "title": "Tullow Oil: Transaction Expected to Complete in 2Q",
            "description": "<div class=\"body-KX2tCBZq body-nzzZVyQ3 content-nzzZVyQ3\"><div class=\"symbolsContainer-uFduEtAF logosContainer-diQOvrPB\" data-no-swipe=\"true\"></div><div><span class=\"placeholder-diQOvrPB\">This news item displays a headline only and has no other text.</span></div></div>",
            "link": "https://www.tradingview.com/news/DJN_DN20260226011966_20260226011980:0/",
            "pub_date": "2026-02-27 00:53:00",
            "source": "Dow Jones Newswires",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "DJN_DN20260226011978:0",
            "title": "Revolution Medicines Is Maintained at Overweight by Piper Sandler",
            "description": "<div class=\"body-KX2tCBZq body-nzzZVyQ3 content-nzzZVyQ3\"><div class=\"symbolsContainer-uFduEtAF logosContainer-diQOvrPB\" data-no-swipe=\"true\"></div><div><span><p class=\"\"><strong class=\"root-Tkn6WL2y\"><span>(16:53 GMT) </span></strong><span>Revolution Medicines Price Target Raised to $120.00/Share From $75.00 by Piper Sandler</span></p></span></div></div>",
            "link": "https://www.tradingview.com/news/DJN_DN20260226011978:0/",
            "pub_date": "2026-02-27 00:53:00",
            "source": "Dow Jones Newswires",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "tag:reuters.com,2026:newsml_FWN3ZM1AV:0",
            "title": "Carrefour Places 500 Million Euros 10-Year Sustainability-Linked Bond",
            "description": "<div class=\"body-KX2tCBZq body-nzzZVyQ3 content-nzzZVyQ3\"><div class=\"symbolsContainer-uFduEtAF logosContainer-diQOvrPB\" data-no-swipe=\"true\"></div><div><span><p class=\"\"><span>Carrefour SA </span><span>:</span></p><ul class=\"list-bmN0_SHH list--padded-bmN0_SHH\"><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>SUCCESS OF A 500 MILLION EUROS 10-YEAR SUSTAINABILITY-LINKED BOND</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>COUPON: 3.875% PER ANNUM</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>ISSUE WAS OVERSUBSCRIBED ALMOST 6 TIMES</span></p></li></ul></span></div></div>",
            "link": "https://www.tradingview.com/news/reuters.com,2026:newsml_FWN3ZM1AV:0-carrefour-places-500-million-euros-10-year-sustainability-linked-bond/",
            "pub_date": "2026-02-27 00:53:05",
            "source": "Reuters",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "tag:reuters.com,2026-02-26:newsml_RSZ5967Ua:0",
            "title": "REG - Maven Inc&Grwth 5 - Transaction in Own Shares",
            "description": "<div class=\"body-KX2tCBZq body-nzzZVyQ3 content-nzzZVyQ3\"><div class=\"symbolsContainer-uFduEtAF logosContainer-diQOvrPB\" data-no-swipe=\"true\"></div><div><span><span>RNS Number : 5967U  Maven Income and Growth VCT 5 PLC  26 February 2026   </span><p class=\"\"><span>Maven Income and Growth VCT 5 PLC (\"the Company\")</span></p><p class=\"\"><span>Share Buy-back and Total Voting Rights</span></p><p class=\"\"><span>On 26 February 2026, Maven Income and Growth VCT 5 PLC purchased, for cancellation, 2,669,710 of its own Ordinary Shares at a price of 28.9p per share.</span></p><p class=\"\"><span>As a result, and in accordance with the Financial Conduct Authority's Disclosure Guidance and Transparency Rules, the Company confirms that its issued share capital as at close of business on 26 February 2026 comprises 250,971,935 Ordinary Shares of 10p each, with each share carrying one voting right.</span></p><p class=\"\"><span>The above figure may be used by Shareholders as the denominator for the calculations by which they will determine if they are required, under the Disclosure Guidance and Transparency Rules, to notify their interest, or a change to their interest, in the Company.</span></p><p class=\"\"><span>On behalf of the Board</span></p><p class=\"\"><span>Maven Capital Partners UK LLP</span></p><p class=\"\"><span>Secretary</span></p><p class=\"\"><span>26 February 2026</span></p><span>This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.</span><p class=\"\"><span>RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.   END  POSAKABPABKDDBB</span></p></span></div></div>",
            "link": "https://www.tradingview.com/news/reuters.com,2026-02-26:newsml_RSZ5967Ua:0-reg-maven-inc-grwth-5-transaction-in-own-shares/",
            "pub_date": "2026-02-27 00:53:14",
            "source": "London Stock Exchange",
            "kind": 1,
            "language": "en"
        }
    ]
}